Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

A DNA aptamer targeting the PA endonuclease domain provided cross-protection against infections of different subtypes of influenza A virus

International Conference on Influenza

Bojian Zheng, Shuofeng Yuan and Jie Zhou

University of Hong Kong, Hong Kong

Posters-Accepted Abstracts: J Infect Dis Ther

DOI: 10.4172/2332-0877.C1.006

Abstract
Amino acid residues in the N-terminal of the PA subunit (PAN) of the Influenza A polymerase play critical roles in endonuclease activity, protein stability and vRNA promoter binding. In addition, PAN is highly conserved among different subtypes of the influenza virus, which suggests PAN to be a desirable target for the development of anti-influenza agents. We selected DNA aptamers targeting the intact PA protein or the PAN domain of an H5N1 virus strain using systematic evolution of ligands by exponential enrichment (SELEX). Binding affinities of selected aptamers were measured, followed by evaluation of in vitro endonuclease inhibitory activity. Next, antiviral effects of enriched aptamers against influenza A virus infections were further examined. A total of three aptamers targeting PA and six aptamers targeting PAN were selected. Our data demonstrated that all three PA-selected aptamers neither inhibited endonuclease activity nor exhibited antiviral efficacy, whereas four of the six PAN-selected aptamers inhibited both endonuclease activity and H5N1 virus infection. These results suggested that PAN functional domain might be a better target than the intact PA protein for the screening of antiviral agents. Among the four effective aptamers, one exhibited cross-protection against infections of H1N1, H5N1, H7N7 and H7N9 influenza viruses with 50% inhibitory concentration (IC50) around 10 nM. Notably, this aptamer was identified at the 5th round but disappeared after the 10th round of the selection, suggesting that the identification and evaluation of aptamers at early rounds of the selection may be highly helpful for screening effective aptamers. Overall, our study provides novel insights for screening and developing effective aptamers as anti-influenza drugs.
Biography

Email: bzheng@hkucc.hku.hk

Top